Patents Assigned to Sessions Pharmaceuticals Inc.
  • Publication number: 20140163505
    Abstract: A foam-based wound dressing for covering a wound on an extremity. The wound dressing includes a composite body having two distinct layers joined along a portion of their perimeters to form a least one open end. Each layer includes a hydrophilic foam matrix attached to a urethane film.
    Type: Application
    Filed: April 4, 2012
    Publication date: June 12, 2014
    Applicant: SESSIONS PHARMACEUTICALS INC.
    Inventor: Leslie Clemens
  • Patent number: 8486454
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic pain in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic pain.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: July 16, 2013
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 8101206
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of swelling and/or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of swelling and/or inflammation.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: January 24, 2012
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 7875294
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Grant
    Filed: September 28, 2006
    Date of Patent: January 25, 2011
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Roger Sessions, legal representative, Alan R. Kahn
  • Publication number: 20100267640
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic swelling and/or neurogenic inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic swelling and/or neurogenic inflammation.
    Type: Application
    Filed: April 26, 2010
    Publication date: October 21, 2010
    Applicant: Sessions Pharmaceuticals, Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 7709005
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic swelling and/or neurogenic inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic swelling and/or neurogenic inflammation.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: May 4, 2010
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Publication number: 20100106122
    Abstract: A wound dressing including a composite body of predetermined length adapted for insertion into a wound cavity. The composite body includes a hydrophilic foam matrix. A first layer of polymer-based mesh is disposed at a first position within the foam matrix and at least a second layer of polymer-based mesh is disposed at a second position within the foam matrix in spaced apart opposing relation to the first layer of polymer-based mesh. The first layer of polymer-based mesh and the second layer of polymer-based mesh are in sandwiching relation to a foam core. The wound dressing provides among other advantages strength and substantially enhanced wicking action.
    Type: Application
    Filed: October 26, 2009
    Publication date: April 29, 2010
    Applicant: SESSIONS PHARMACEUTICALS INC.
    Inventor: Leslie CLEMENS
  • Patent number: 7625585
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a neurogenic bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: December 1, 2009
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: D636881
    Type: Grant
    Filed: February 10, 2009
    Date of Patent: April 26, 2011
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Leslie Clemens, John J. Newton, Jr.